Insider · CIK 0001342821

Himawan Jeff

Reports to the SEC for 4 companies · NORTHBROOK, IL

sec.gov

Transactions

Companies

Filings

CIK

0001342821

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−44.5K sh	$116.50	−$5.19M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−7,873 sh	$116.50	−$917K	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−36.6K sh	$116.50	−$4.26M	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.1K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,016 sh	—	—	0
2023-09-26	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+32.2K sh	$13.87	+$446K	44,546
2023-09-26	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−32.2K sh	—	—	0
2023-07-27	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,016 sh	—	—	4,016
2023-05-09	Horizon Therapeutics Public Ltd CoG Gift	Director	GGift	+7,873 sh	—	—	7,873
2023-05-09	Horizon Therapeutics Public Ltd CoG Gift	Director	GGift	−7,873 sh	—	—	2,121
2023-04-28	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+3,913 sh	—	—	11,873
2023-04-28	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,879 sh	$111.16	−$209K	9,994
2023-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,913 sh	—	—	0
2022-12-30	Horizon Therapeutics Public Ltd CoG Gift	Director	GGift	−2,230 sh	—	—	7,960
2022-04-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+4,223 sh	—	—	58,202
2022-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,223 sh	—	—	0
2022-04-29	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,139 sh	$98.56	−$112K	57,063
2022-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+3,913 sh	—	—	3,913
2021-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	0
2021-04-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	—	—	53,979
2021-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,223 sh	—	—	4,223
2020-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.4K sh	—	—	0
2020-05-02	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,151 sh	$35.62	−$148K	42,881
2020-05-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.4K sh	—	—	47,032
2020-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+11.1K sh	—	—	11,098
2019-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,132 sh	$26.54	−$110K	31,642
2019-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.3K sh	—	—	35,774
2019-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.3K sh	—	—	0
2019-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+15.4K sh	—	—	15,390
2018-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+15.3K sh	—	—	15,320
2018-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+32.2K sh	—	—	32,161
2018-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14.1K sh	—	—	0
2018-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−3,790 sh	$13.87	−$52.6K	20,454
2018-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+14.1K sh	—	—	24,244
2017-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+31.2K sh	—	—	31,153
2017-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14K sh	—	—	0
2017-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−3,763 sh	$15.12	−$56.9K	10,190
2017-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+14.1K sh	—	—	14,054
2017-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+14K sh	—	—	13,953
2016-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+23.1K sh	—	—	23,092
2016-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+14K sh	—	—	13,953
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Warrant (Right to Buy)J Other	Director, 10% Owner	JOther	+17.8K sh	—	—	17,757
2015-08-20	GYREGYRE THERAPEUTICS, INC.J Other	Director, 10% Owner	JOther	+77.1K sh	—	—	1,145,849
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Warrant (Right to Buy)J Other	Director, 10% Owner	JOther	+1,280 sh	—	—	1,280
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Warrant (Right to Buy)J Other	Director, 10% Owner	JOther	+1,580 sh	—	—	1,580
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Warrant (Right to Buy)J Other	Director, 10% Owner	JOther	+687 sh	—	—	687
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Warrant (Right to Buy)J Other	Director, 10% Owner	JOther	+220 sh	—	—	220
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Warrant (Right to Buy)J Other	Director, 10% Owner	JOther	+96 sh	—	—	96
2015-08-20	GYREGYRE THERAPEUTICS, INC.J Other	Director, 10% Owner	JOther	+1.07M sh	—	—	1,068,790

Recent filings

Accepted (ET)
Oct 64
Himawan Jeff0001209191-23-052371
SEC(opens sec.gov)
Sep 274
Himawan Jeff0001209191-23-050674
SEC(opens sec.gov)
Jul 284
Himawan Jeff0001209191-23-043687
SEC(opens sec.gov)
May 114
Himawan Jeff0001209191-23-028795
SEC(opens sec.gov)
May 24
Himawan Jeff0001209191-23-026752
SEC(opens sec.gov)
Jan 44
Himawan Jeff0001209191-23-000863
SEC(opens sec.gov)
May 24
Himawan Jeff0001209191-22-026462
SEC(opens sec.gov)
Apr 304
Himawan Jeff0001209191-21-029362
SEC(opens sec.gov)

Companies

Address

C/O HORIZON PHARMA, INC. 1033 SKOKIE BLVD., SUITE 355

NORTHBROOK, IL, 60062